Vaccinex annual current ratio
2017
2018
2019
2020
2021
2022
2023
2024
Vaccinex Current Ratio Growth & History (VCNX)
Vaccinex's current ratio was 0.50 for fiscal 2024.
View full Vaccinex company overviewVaccinex annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2024 | 2024-12-31 | 0.50 | −0.07 | −12.06% |
| 2023 | 2023-12-31 | 0.57 | −2.38 | −80.79% |
| 2022 | 2022-12-31 | 2.95 | −1.22 | −29.30% |
| 2021 | 2021-12-31 | 4.17 | 3.31 | +386.85% |
| 2020 | 2020-12-31 | 0.86 | 0.27 | +46.87% |
| 2019 | 2019-12-31 | 0.58 | −2.62 | −81.81% |
| 2018 | 2018-12-31 | 3.20 | 2.01 | +168.31% |
| 2017 | 2017-12-31 | 1.19 | — | — |
Vaccinex quarterly current ratio
Q4.17
Q2.18
Q3.18
Q4.18
Q4.19
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q4 2024 | 2024-12-31 | 0.50 | −0.07 | −12.06% |
| Q3 2024 | 2024-09-30 | 0.77 | 0.42 | +122.17% |
| Q2 2024 | 2024-06-30 | 0.42 | −0.37 | −46.84% |
| Q1 2024 | 2024-03-31 | 1.52 | −0.39 | −20.52% |
| Q4 2023 | 2023-12-31 | 0.57 | −2.38 | −80.79% |
| Q3 2023 | 2023-09-30 | 0.35 | −3.69 | −91.41% |
| Q2 2023 | 2023-06-30 | 0.79 | −7.43 | −90.37% |
| Q1 2023 | 2023-03-31 | 1.91 | −8.09 | −80.87% |
| Q4 2022 | 2022-12-31 | 2.95 | −1.22 | −29.30% |
| Q3 2022 | 2022-09-30 | 4.04 | −2.83 | −41.17% |
| Q2 2022 | 2022-06-30 | 8.22 | 4.12 | +100.48% |
| Q1 2022 | 2022-03-31 | 10.00 | 5.52 | +123.25% |
| Q4 2021 | 2021-12-31 | 4.17 | 3.31 | +386.85% |
| Q3 2021 | 2021-09-30 | 6.86 | 5.55 | +420.47% |
| Q2 2021 | 2021-06-30 | 4.10 | 3.76 | +1102.03% |
| Q1 2021 | 2021-03-31 | 4.48 | — | — |
| Q4 2020 | 2020-12-31 | 0.86 | 0.27 | +46.87% |
| Q3 2020 | 2020-09-30 | 1.32 | — | — |
| Q2 2020 | 2020-06-30 | 0.34 | — | — |
| Q4 2019 | 2019-12-31 | 0.58 | −2.62 | −81.81% |
| Q4 2018 | 2018-12-31 | 3.20 | 2.01 | +168.31% |
| Q3 2018 | 2018-09-30 | 4.78 | — | — |
| Q2 2018 | 2018-06-30 | 0.28 | — | — |
| Q4 2017 | 2017-12-31 | 1.19 | — | — |
Vaccinex current ratio trends
Over the last five fiscal years, Vaccinex's current ratio decreased from 0.58 to 0.50, a change of −0.09. The latest reported quarter, Q4 2024, shows 0.50.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Vaccinex source filings ↗